These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6099768)

  • 21. Hyperthermic response of the cat to intraventricular injection of the opioid delta-receptor agonist D-Ala2-D-Leu5-enkephalin.
    Pang IH; Bernardini GL; Clark WG
    Brain Res Bull; 1984 Aug; 13(2):263-8. PubMed ID: 6093942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressor and bradycardic effects induced by spinal subarachnoid injection of D-Ala2-D-Leu5-enkephalin in rats.
    Li SJ; Zhang X; Ingenito AJ
    Neuropeptides; 1988; 12(2):81-8. PubMed ID: 2847073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitro.
    Rothman RB; Danks JA; Pert CB; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1984 May; 4(3):261-8. PubMed ID: 6087192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
    Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
    Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actions of D-Ala2-D-Leu5-enkephalin and dynorphin A (1-17) on neocortical neurons in vitro.
    Sutor B; Zieglgänsberger W
    Neuropeptides; 1984 Dec; 5(1-3):241-4. PubMed ID: 6152323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A; Metsch R
    Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are delta-opioid receptors involved in the regulation of food and water intake?
    Jackson HC; Sewell RD
    Neuropharmacology; 1985 Sep; 24(9):885-8. PubMed ID: 2997654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin).
    Ukai M; Toyoshi T; Kameyama T
    Neuropharmacology; 1989 Oct; 28(10):1033-9. PubMed ID: 2554179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic activity of substance P in rats: tolerance and cross-tolerance with enkephalin.
    Naranjo JR; Fernandez-Tome MP; Del Rio J
    Eur J Pharmacol; 1984 Feb; 98(1):133-6. PubMed ID: 6201370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of (D-Ala2,D-Leu5)enkephalinamide on isolated longitudinal muscle guinea pig and rat intestines.
    Venkova K; Radomirov R; Petkov VD
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):291-6. PubMed ID: 3613757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central opioid receptors and baroreflex control of sympathetic and cardiovascular function.
    Gordon FJ
    J Pharmacol Exp Ther; 1986 May; 237(2):428-36. PubMed ID: 3009782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Audiogenic seizures during ethanol withdrawal can be blocked by a delta opioid agonist.
    Kotlińska J; Langwiński R
    Drug Alcohol Depend; 1986 Dec; 18(4):361-7. PubMed ID: 3028746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The site (central or peripheral) of the anti-ulcer action of dalargin, a synthetic analog of endogenous opioids in an experimental model of cysteamine-induced duodenal ulcer in rats].
    Polonskiĭ VM; Iarygin KN; Krivosheev OG; Moskovkin GN; Vinogradov VA
    Biull Eksp Biol Med; 1987 Apr; 103(4):433-4. PubMed ID: 3032303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of di- and trivalent metal ions on the complexing of D-ala2, D-leu5-enkephalin with opiate receptors of brain membrane preparations].
    Zaĭtsev SV; Porodenko NV; Varfolomeev SD
    Dokl Akad Nauk SSSR; 1984; 277(5):1260-3. PubMed ID: 6094131
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of opiate agonists administered intrathecally on the behavioral and hemodynamic manifestations of pain].
    Zaĭtsev AA; Petriaevskaia NV; Khvan AA
    Farmakol Toksikol; 1988; 51(1):23-5. PubMed ID: 2834219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Pharmacol Biochem Behav; 1992 Jan; 41(1):171-6. PubMed ID: 1311454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebroventricular administration of superFIT and its enantiomer to rats: evidence for in vivo acylation of [3H]DADL binding sites.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC
    Neuropeptides; 1987 Apr; 9(3):207-10. PubMed ID: 3037427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiopioid activity of the cardioexcitatory peptide in central modulation of cardiovascular functions.
    Chai SH; Tang J; Han JS
    Eur J Pharmacol; 1986 Nov; 130(3):315-8. PubMed ID: 3792453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.